Literature DB >> 1424255

Generalized elastosis perforans serpiginosa in Down's syndrome.

B O'Donnell1, P Kelly, P Dervan, F C Powell.   

Abstract

Elastosis perforans serpiginosa is a rare disorder of epidermal perforation characterized by the extrusion of dermal elastic tissue through the epidermis. Its aetiology is unknown, but there is histological and biochemical evidence of an abnormality of elastic tissue. Three forms of elastosis perforans serpiginosa exist. It may be either idiopathic, iatrogenic, or, in approximately one quarter of cases, associated with certain genetically determined disorders of connective tissue. Cutaneous lesions appear between the ages of 6 and 20 years, and persist for 6 months to 5 years. They may be confined to one anatomic area, or less frequently are disseminated. We review the case of a 28-year-old woman with recent onset of unusually extensive elastosis perforans serpiginosa with co-existing Down's syndrome and (secondary) sclerosing cholangitis.

Entities:  

Mesh:

Year:  1992        PMID: 1424255     DOI: 10.1111/j.1365-2230.1992.tb02529.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  4 in total

1.  Primary sclerosing cholangitis preceding Crohn's disease in a child with Down's syndrome.

Authors:  P Vajro; S Cucchiara; A Vegnente; R Iorio; C de Silva; L Cipolletta; M A Bianco
Journal:  Dig Dis Sci       Date:  1998-01       Impact factor: 3.199

2.  Elastosis perforans serpiginosa in association with scabies mite.

Authors:  Michael Kassardjian; Julie Frederickson; Jack Griffith; Paul Shitabata; David Horowitz
Journal:  J Clin Aesthet Dermatol       Date:  2013-10

3.  Penicillamine-induced Elastosis Perforans Serpiginosa and Cutis Laxa in a Patient with Wilson's Disease.

Authors:  Se Young Na; Mira Choi; Min Ji Kim; Jong Hee Lee; Soyun Cho
Journal:  Ann Dermatol       Date:  2010-11-05       Impact factor: 1.444

Review 4.  Skin Manifestations Associated with Autoimmune Liver Diseases: a Systematic Review.

Authors:  Benedetta Terziroli Beretta-Piccoli; Pietro Invernizzi; M Eric Gershwin; Carlo Mainetti
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 10.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.